| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.10B | 16.60B | 16.55B | 8.64B | 3.91B | 1.33B |
| Gross Profit | 10.00B | 10.03B | 12.02B | 6.62B | 3.11B | 1.03B |
| EBITDA | 4.62B | 5.31B | 8.46B | 4.51B | 2.10B | 563.14M |
| Net Income | 2.49B | 2.75B | 5.79B | 2.65B | 1.33B | 368.16M |
Balance Sheet | ||||||
| Total Assets | 14.25B | 8.12B | 12.00B | 8.33B | 4.23B | 1.35B |
| Cash, Cash Equivalents and Short-Term Investments | 6.28B | 4.12B | 10.17B | 7.43B | 3.98B | 1.18B |
| Total Debt | 6.12B | 939.06M | 58.76M | 101.71M | 136.30M | 150.06M |
| Total Liabilities | 8.72B | 3.02B | 2.98B | 2.73B | 1.30B | 575.81M |
| Stockholders Equity | 5.53B | 5.10B | 9.02B | 5.60B | 2.93B | 777.77M |
Cash Flow | ||||||
| Free Cash Flow | -1.92B | 847.97M | 5.32B | 3.90B | 2.06B | 653.47M |
| Operating Cash Flow | 3.30B | 976.60M | 5.48B | 3.96B | 2.08B | 678.97M |
| Investing Cash Flow | -5.44B | -251.20M | -308.34M | -400.20M | -79.29M | -57.29M |
| Financing Cash Flow | -1.67B | -6.68B | -2.43B | -110.48M | 804.89M | -347.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥87.38B | 17.15 | ― | 4.32% | 11.99% | -4.74% | |
76 Outperform | ¥239.16B | 16.18 | 26.65% | 4.00% | 10.37% | 18.68% | |
75 Outperform | ¥118.78B | 24.27 | ― | 1.54% | 17.13% | 23.53% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥41.06B | 17.02 | ― | 0.45% | 0.32% | -48.88% |
Quants Research Institute Holdings, Inc. has issued a correction to previously released consolidated financial results for the fiscal year ended September 2025 under IFRS. The company said an error was found in its earlier disclosure, prompting it to update its guidance for key profit metrics in the fiscal year ending September 30, 2026.
While the revenue forecast remains unchanged at ¥22,184 million with year-on-year growth of 33.6%, the company revised upward the projected growth rates for operating profit, profit before tax, and profit attributable to owners of the parent. These profit growth rates are now expected to be 25.4%, 23.4%, and 28.6%, respectively, compared with lower percentages previously disclosed, suggesting a more robust profitability outlook for shareholders without altering the absolute forecast figures or earnings per share.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1366.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
Quants Research Institute Holdings released its financial results presentation for the first quarter of fiscal year 2026/9, outlining recent earnings performance and management’s view on the current business environment. The disclosure is aimed at updating investors on the company’s operating trends and financial standing at the start of the fiscal year.
The presentation also sets out the full-year earnings forecast, along with a medium- to long-term growth strategy designed to strengthen its market position in quantitative research services. By framing these plans alongside a business overview and competitive advantages, the company signals its intention to pursue sustained growth and reinforce its standing with stakeholders.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1366.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
Quants Research Institute Holdings reported revenue of ¥4.67 billion for the quarter ended December 31, 2025, up 11.8% year on year, but operating profit dropped 31.2% to ¥1.14 billion as quarterly profit attributable to owners fell 35.7% to ¥688 million, reflecting margin pressure despite top-line growth. Total assets rose sharply to ¥14.25 billion from ¥8.12 billion, while the equity ratio declined from 62.8% to 38.8%, and the company maintained its full-year forecast for strong double-digit growth in revenue and profit, signaling confidence in its outlook even as it projects no dividends for the current fiscal year.
The company plans full-year revenue of ¥22.18 billion, a 33.6% increase, and profit attributable to owners of ¥3.53 billion, up 28.6%, implying a recovery in profitability over the remainder of the fiscal year. The decision to forecast zero dividends, after paying ¥5 per share in the prior year, suggests a strategic emphasis on retaining capital to support expansion or balance sheet needs, which may affect income-focused shareholders but could underpin longer-term growth and competitiveness in its niche financial research market.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1366.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
Quants Research Institute Holdings reported flat revenue of ¥16.6 billion for the fiscal year ended September 2025, but operating profit fell 42.1% and profit attributable to owners of the parent dropped 51.4% to ¥2.75 billion, reflecting a sharp deterioration in profitability and a decline in total assets and equity. The company nonetheless initiated a ¥5 per share year-end dividend, bought back and retired a significant number of shares, and added two new subsidiaries—M&A Research Institute Singapore and Souken Leasing—to its consolidation scope, while forecasting a strong rebound in FY2026 with revenue expected to rise 33.6% and profit attributable to owners up 22.1%, signaling confidence in earnings recovery and continued business expansion.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1268.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. disclosed that its Representative Director and CEO, Shunsaku Sagami, is a controlling shareholder holding 58.01% of the company’s voting rights, underscoring his significant influence over corporate governance. The company reported there are currently no transactions with the controlling shareholder that require disclosure, and emphasized that any future dealings with controlling shareholders will be reviewed by the Board of Directors to ensure fair terms and compliance with laws, with the stated aim of preventing disadvantages to the company and protecting minority shareholders’ interests.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1268.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced that it will receive a 3.6 billion yen dividend from its consolidated subsidiary, M&A Research Institute Inc., with the payment scheduled for December 25, 2025. The dividend will be recognized as revenue in the parent company’s non-consolidated financial statements for the fiscal year ending September 2026, but will not affect its consolidated financial results, underscoring that the transaction is an internal capital transfer with limited impact on the group’s overall earnings profile.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1268.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. announced a proposed change of its trade name to Quants Research Institute Holdings, Inc., reflecting its strategic shift towards diversified business domains and a commitment to data-driven growth. This change, pending shareholder approval, signifies the company’s long-term vision of enhancing corporate and social value through innovative approaches.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen1419.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.